| ||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Copyright © 2009. National Academy of Sciences. All rights reserved. Terms of Use and Privacy Statement |
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 11
INTERNATIONAL BENCHMARKING OF US IMMUNOLOGY RESEARCH
CONTENTS
EXECUTIVE SUMMARY
15
1.
INTRODUCTION
1.1 How Important Is It for The US To Lead In Immunology Research?
17
1.2 What Is Immunology?
17
1.3 Immunology As An Academic Discipline
18
1.4 What Is The International Nature Of Immunology?
19
1.5 What Are Some Caveats?
19
1.6 Panel Charge and Rationale
19
2.
BENCHMARKING RESULTS
2.1 Methods
21
2.1.1 Reputation Survey
21
2.1.2 Citation Analysis
24
2.1.3 Journal Publication Analysis
24
2.2 Results
26
2.2.1 Reputation Survey
26
2.2.2 Citation Analysis
28
2.2.3 Journal Publication Analysis
28
2.3 Summary
29
3.
KEY FACTORS
3.1 Funding
35
3.2 Human Resources
37
3.3 Infrastructure
37
3.4 Biotechnology and Pharmaceutical Firms
38
3.5 The Clinical Trial
39
4.
LIKELY FUTURE POSITION
4.1 Funding and Resource Limitations
43
4.2 Increased Competition from Europe and Other Countries
44
4.3 Clinical Immunology and the Shift Toward HMOs
44
4.4 Training of US Students
45
5.
SUMMARY AND CONCLUSIONS
5.1 The United States Is The World Leader In All The Major Subfields Of Immunology But Is Only Among The World Leaders In Some Specific Sub-Subfields.
51
5.2 Flexibility To Pursue Original And Innovative Research Ideas Has Attracted Both Domestic And International Human Capital. Federal, State, And Private Funding Have All Contributed To A Climate Ripe For This Innovative Research.
51
5.3 Industrial Interests Have Fostered Many Striking Breakthroughs In
OCR for page 12
INTERNATIONAL BENCHMARKING OF US IMMUNOLOGY RESEARCH
Immunology.
52
5.4 A Scarcity Of Large-Scale Clinical Trials In Immunology Can Be Attributed To Shortages Of Funding And Of Qualified Personnel. In Addition, Increasing Dominance Of Managed Care Means That Fewer Patients Are Available To Academic Institutions For Clinical Trials.
52
5.5 Shifting Federal And Industry Priorities, A Potential Reduction In Access To Domestic And Foreign Talent, And The Increasing Cost Of Maintaining Mouse Facilities Could Curtail US Ability To Capitalize On Leadership Opportunities.
52
6.
REFERENCES
55
7.
APPENDIX: PANEL AND STAFF BIOGRAPHICAL INFORMATION
57
OCR for page 13
INTERNATIONAL BENCHMARKING OF US IMMUNOLOGY RESEARCH
TABLES AND GRAPHS
Figure 2.1:
Contribution of United States and Other Nations to Immunology Papers in 1981-1996,
22
Figure 2.2:
Percentage of the World's Papers in Immunology in 1981-1996 by Country,
23
Figure 2.3:
Contribution of United States and Other Nations to Immunology Citations in 1981-1997,
25
Figure 2.4:
Percentage of World's Citations in Immunology in 1981-1997 by Country,
31
Figure 3.1:
U.S. Net Trade Balance: Biotechnology,
42
Figure 4.1:
Number of PhD Students in Immunology in the United States, 1977-1996,
46
Figure 4.2:
Percentage of US Citizen and Permanent-Resident PhD Students in Immunology Supported by National Institutes of Health, 1977-1996,
48
Table 2.1:
Immunology International Reputation Survey Results,
27
Table 2.2:
Relative Citation Impact by Country, 1981-1997,
30
Table 2.3:
Authorship of Immunology Papers in Blood, 1995-1997,
32
Table 2.4:
Authorship of Immunology Papers in Cell, 1995-1997,
32
Table 2.5:
Authorship of Immunology Papers in Immunity, 1995-1997,
32
Table 2.6:
Authorship of Immunology Papers in Nature, 1995-1997,
33
Table 2.7:
Authorship of Immunology Papers in Science, 1995-1997,
33
Table 2.8
Authorship of Immunology Papers in the Journal of Experimental Medicine, February 1996 - July 1996,
33
Table 3.1:
Analysis of Nobel Prizes Presented for Immunology Research,
38
Table 3.2:
Industry Comparable Metrics (Ecu in Millions),
40
Table 3.3:
Entrepreneurial Life Sciences Highlights (Ecu in Millions),
41
Table 4.1:
NIH Trainee and Fellowship Support in Immunology,
47
Table 4.2:
Employment Status of Doctorates in Immunology,
49
OCR for page 14
INTERNATIONAL BENCHMARKING OF US IMMUNOLOGY RESEARCH
This page in the original is blank.
Representative terms from entire chapter:
immunology research
Items in cart [1]
